Long term follow-up of the STOPAGO study

Cottu, Adrien; Guillet, Stéphanie; Viallard, Jean-François; Riviere, Etienne; Cheze, Stéphane; Gobert, Delphine; Neel, Antoine; Graveleau, Julie; Marolleau, Jean-Pierre; Lefrere, François; Moulis, Guillaume; Lega, Jean-Christophe; Moignet, Aline; Robbins, Ailsa; Crickx, Etienne; Boutin, Emmanuelle; Noel, Nicolas; Malphettes, Marion; Galicier, Lionel; Audia, Sylvain; Bonnotte, Bernard; Lambotte, Olivier; Fain, Olivier; Gerfaud-Valentin, Mathieu; Terriou, Louis; Martis, Nihal; Morin, Anne-Sophie; Perlat, Antoinette; Le Gallou, Thomas; Roy-Peaud, Frédérique; Puyade, Matthieu; Comont, Thibault; Limal, Nicolas; Languille, Laetitia; Michel, Marc; Godeau, Bertrand; Mahevas, Matthieu

doi:10.1182/blood.2024025707

An open prospective, multicenter study enrolled 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained a sustained response off treatment 4 years after treatment discontinuation. NCT03119974

This content is only available as a PDF.

2024

You do not currently have access to this content.

Sign in via your Institution

Long term follow-up of the STOPAGO study

Article PDF first page preview

24-Hour Access

Cited By

Email alerts

ASH Publications

American Society of Hematology

Long term follow-up of the STOPAGO study

Article PDF first page preview

This feature is available to Subscribers Only

My Account

My Account

24-Hour Access

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only